FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ Buys 3, Sells 2 in 3rd Quarter

FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ recently filed their 13F report for the third quarter of 2022, which ended on 2022-09-30.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

303 BROADWAY Cincinnati, OH 45202

As of the latest 13F report, the guru’s equity portfolio contained 401 stocks valued at a total of $11.96Bil. The top holdings were MSFT(4.66%), AAPL(3.88%), and CTAS(3.45%).

According to GuruFocus data, these were FORT WASHINGTON INVESTMENT ADVISORS INC /OH/’s top five trades of the quarter.

Touchstone Strategic Income Opportunities ETF


The guru established a new position worth 4,000,000 shares in ARCA:SIO, giving the stock a 0.8% weight in the equity portfolio. Shares traded for an average price of $24.97 during the quarter.

On 10/26/2022, Touchstone Strategic Income Opportunities ETF traded for a price of $23.8422 per share and a market cap of $96.04Mil. The stock has returned 0.00% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, Touchstone Strategic Income Opportunities ETF has a price-earnings ratio of 13.00 and a price-book ratio of 1.86.

Touchstone Ultra Short Income ETF


The guru established a new position worth 1,914,000 shares in BATS:TUSI, giving the stock a 0.4% weight in the equity portfolio. Shares traded for an average price of $25.01 during the quarter.

On 10/26/2022, Touchstone Ultra Short Income ETF traded for a price of $24.92 per share and a market cap of $51.17Mil. The stock has returned 0.00% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

Fox Corp


FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ reduced their investment in NAS:FOXA by 1,128,081 shares. The trade had a 0.28% impact on the equity portfolio. During the quarter, the stock traded for an average price of $33.85.

On 10/26/2022, Fox Corp traded for a price of $29.63 per share and a market cap of $15.88Bil. The stock has returned -27.49% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Fox Corp has a price-earnings ratio of 14.14, a price-book ratio of 1.44, a price-earnings-to-growth (PEG) ratio of 3.07, a EV-to-Ebitda ratio of 7.55 and a price-sales ratio of 1.19.

The price-to-GF Value ratio is 0.71, earning the stock a GF Value rank of 9.

Boeing Co


During the quarter, FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ bought 262,945 shares of NYSE:BA for a total holding of 424,562. The trade had a 0.27% impact on the equity portfolio. During the quarter, the stock traded for an average price of $153.37.

On 10/26/2022, Boeing Co traded for a price of $147.1896 per share and a market cap of $87.08Bil. The stock has returned -31.11% over the past year.

GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 6 out of 10.

In terms of valuation, Boeing Co has a EV-to-Ebitda ratio of -83.02 and a price-sales ratio of 1.43.

The price-to-GF Value ratio is 0.67, earning the stock a GF Value rank of 10.

Bristol-Myers Squibb Co


FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ reduced their investment in NYSE:BMY by 440,343 shares. The trade had a 0.26% impact on the equity portfolio. During the quarter, the stock traded for an average price of $72.54.

On 10/26/2022, Bristol-Myers Squibb Co traded for a price of $72.9 per share and a market cap of $155.38Bil. The stock has returned 29.61% over the past year.

GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Bristol-Myers Squibb Co has a price-earnings ratio of 24.18, a price-book ratio of 4.77, a price-earnings-to-growth (PEG) ratio of 3.02, a EV-to-Ebitda ratio of 9.53 and a price-sales ratio of 3.39.

The price-to-GF Value ratio is 0.96, earning the stock a GF Value rank of 5.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.